Incyte is paying $150 million upfront for worldwide rights to…
https://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.png00adminhttps://cancure.com/wp-content/uploads/2015/05/Cancure_Logo_Website_v01.pngadmin2017-10-26 09:04:412017-11-01 09:15:40Incyte pays MacroGenics $150M for PD-1 inhibitor
